Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Rachel Y. Chen"'
Autor:
Abdulazeez Salawu, Alberto Hernando-Calvo, Rachel Y. Chen, Daniel V. Araujo, Marc Oliva, Zhihui A. Liu, Lillian L. Siu
Background: Phase 1 immuno-oncology (IO) trials frequently involve pharmacodynamic (PD) biomarker assessments involving tumour biopsies and/or blood collection, with increasing use of molecular imaging. PD biomarkers are set to play a fundamental rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039b89fa820a189d2cd527e0a2e24b35
http://hdl.handle.net/2445/191340
http://hdl.handle.net/2445/191340
Autor:
Alberto Hernando-Calvo, Abdulazeez Salawu, Rachel Y. Chen, Daniel V. Araujo, Marc Oliva, Zhihui Amy Liu, Lillian L. Siu
Publikováno v:
European journal of cancer (Oxford, England : 1990). 175
Despite the increased number of novel immunotherapy (IO) agents under current development, their toxicity profile remains to be fully elucidated.An IO risk stratification model was developed based on 5 different variables: treatment-related deaths; r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4a04768f39c028a0fd8e4cee0d4df41
https://pubmed.ncbi.nlm.nih.gov/36084619
https://pubmed.ncbi.nlm.nih.gov/36084619
